纳米孔测序快速诊断羊膜腔内感染
该前瞻性队列研究纳入有早产症状或未足月胎膜早破的单胎孕妇,评估16S rDNA纳米孔测序诊断羊膜腔内感染的效能。结果显示敏感性88.9%、特异性95.4%、准确性94.2%,微生物负荷与羊水白细胞介素6浓度呈强正相关(Spearman相关系数0.9;P=.002)。
要点
- 16S纳米孔测序诊断羊膜腔内感染的敏感性为88.9%(8/9),特异性为95.4%(41/43)。
- 16S纳米孔测序的诊断准确性为94.2%(49/52),阳性似然比为19.1(95%CI,4.8-75.4)。
- 微生物负荷与羊水白细胞介素6浓度呈强正相关(Spearman相关系数0.9;P=.002)。
核心结论
- 16S纳米孔测序在诊断羊膜腔内感染方面具有较高的诊断指数、预测值、似然比和准确性。
研究设计与样本
- 前瞻性队列研究,纳入有早产症状且胎膜完整或未足月胎膜早破的单胎妊娠孕妇。
- 获取羊水样本,用培养法和聚合酶链反应(PCR)为基础的16S Sanger测序法评估羊膜腔细菌。
- 根据羊水培养、16S Sanger测序和羊水白细胞介素6浓度将参与者分为4组:无羊膜腔内感染和炎症组、无羊膜腔内炎症的微生物入侵组、无菌性羊膜腔内炎症组、羊膜腔内感染组。
- 对照组为孕中期羊膜腔穿刺、无羊膜腔内感染或炎症且足月分娩的患者。
- 进行16S rDNA纳米孔测序,并确定诊断羊膜腔内感染的诊断指标;生物信息学分析鉴定微生物,采用读段数至少100或超过对照组背景物种读段数且相对丰度不低于1%的标准。
主要发现
- 16S纳米孔测序诊断羊膜腔内感染的敏感性为88.9%(8/9),特异性为95.4%(41/43)。
- 阳性预测值为80.0%(8/10),阴性预测值为97.6%(41/42)。
- 阳性似然比为19.1(95%CI,4.8-75.4),阴性似然比为0.1(95%CI,0.02-0.7)。
- 准确性为94.2%(49/52),羊膜腔内感染患病率为17%(9/52)。
- 16S纳米孔测序确定的微生物负荷与羊水白细胞介素6浓度呈强正相关(Spearman相关系数0.9;P=.002)。
关键数值与推荐
- 羊膜腔内感染定义为羊膜腔内炎症且存在微生物(白细胞介素6≥2.6 ng/mL且羊膜腔微生物入侵)。
- 无菌性羊膜腔内炎症定义为白细胞介素6≥2.6 ng/mL且无羊膜腔微生物入侵。
- 16S纳米孔测序的微生物鉴定标准为读段数至少100或超过对照组背景物种读段数,且相对丰度不低于1%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Intraamniotic infection (defined as intraamniotic inflammation with microorganisms) is an important cause of the preterm labor syndrome. Methods for the detection of microorganisms in amniotic fluid are culture and/or polymerase chain reaction assay. However, both methods take time, and the results are rarely available for clinical decision-making. Nanopore sequencing technology offers real-time, long-read sequencing that can produce rapid results. OBJECTIVE: To determine 1) the diagnostic performance of the 16S rDNA nanopore sequencing method for the identification of microorganisms in patients with intraamniotic inflammation and 2) the relationship between microbial burden and the intensity of the amniotic fluid inflammatory response. STUDY DESIGN: We performed a prospective cohort study that included singleton pregnancies presenting with symptoms of preterm labor with intact membranes or of preterm prelabor rupture of the membranes. Amniotic fluid samples were obtained for the evaluation of bacteria in the amniotic cavity using cultivation and polymerase chain reaction-based 16S Sanger sequencing methods. Participants were classified into 4 groups according to the results of an amniotic fluid culture, 16S Sanger sequencing, and an amniotic fluid interleukin 6 concentration: 1) no intraamniotic infection and intraamniotic inflammation (interleukin 6 <2.6 ng/mL, and no microorganisms in the amniotic cavity, as determined by culture or 16S Sanger sequencing); 2) microbial invasion of the amniotic cavity without intraamniotic inflammation, defined by the presence of bacteria detected by culture or 16S Sanger sequencing; 3) sterile intraamniotic inflammation (interleukin 6 ≥2.6 ng/mL without microbial invasion of the amniotic cavity); and 4) intraamniotic infection (interkeukin 6 ≥2.6 ng/mL with microbial invasion of the amniotic cavity). Patients who underwent a mid-trimester amniocentesis, had no intraamniotic infection or intraamniotic inflammation, and delivered at term represented the control group. 16S rDNA nanopore sequencing was performed and the diagnostic indices for the identification of intraamniotic infection were determined. Bioinformatic analysis was carried out to identify microorganisms, and a read count of at least 100 or a read count exceeding that of the background species from the control group, along with a relative abundance of no less than 1%, was used. RESULTS: 1) The 16S nanopore sequencing had a sensitivity of 88.9% (8/9), specificity of 95.4% (41/43), positive predictive value of 80.0% (8/10), negative predictive value of 97.6% (41/42), positive likelihood ratio of 19.1 (95% confidence interval, 4.8-75.4), negative likelihood ratio of 0.1 (95% confidence interval, 0.02-0.7), and an accuracy of 94.2% (49/52) for the identification of intraamniotic infection (prevalence, 17% [9/52]); 2) the microbial load determined by the 16S nanopore sequencing had a strong positive correlation with the intensity of an intraamniotic inflammatory response (amniotic fluid interleukin 6 concentration; Spearman's correlation 0.9; P=.002); and 3) a subgroup of patients with intraamniotic inflammation did not have bacteria determined by culture, Sanger sequencing, or nanopore 16S, thus confirming the existence of sterile intraamniotic inflammation. CONCLUSION: The 16S nanopore sequencing has high diagnostic indices, predictive values, likelihood ratios, and accuracy in the diagnosis of intraamniotic infection.
引用
- Chaemsaithong P, Romero R, Pongchaikul P, et al. The rapid diagnosis of intraamniotic infection with nanopore sequencing. Am J Obstet Gynecol. 2025. PMID: 39952543. doi:10.1016/j.ajog.2025.02.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。